variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
ABCA4-G863A,ABCA4,"Various publications report this variant causes Stargardt Disease in a recessive manner, when combined with another more severe variant. Stargardt disease causes progressive vision loss and blindness.",High,Well-established,Pathogenic,0.0049,Hearing and vision,Recessive,Heterozygous,9054934;10090887;11919200;11973624;18285826,rs76157638,5,chr1,94517254,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
CBS-I278T,CBS,This recessive mutation causes homocystinuria in a recessive manner and is found in patients responsive to pyridoxine treatment.,High,Likely,Pathogenic,0.0029,Genital and urinary;Metabolism,Recessive,Heterozygous,7611293;8554066;8940271;9813456;15972722;19683694,rs5742905,5,chr21,44483184,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
PEX1-I696M,PEX1,"Reported as a mutation causing peroxisome biogenesis disorder in a single patient, presumably in a recessive manner.",High,Uncertain,Pathogenic,0.027,Metabolism,Recessive,Heterozygous,11389485,rs35996821,5,chr7,92132493,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
PPARG-P12A,PPARG,,Moderate,Uncertain,Not Reviewed,0.089,Other,Unknown,Heterozygous,16783862;17213274;17463248,rs1801282,3,chr3,12393125,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
ATM-S49C,ATM,May be associated with a small increased risk of breast cancer.,Low,Uncertain,Pathogenic,0.01,Cancer,Complex/Other,Heterozygous,16652348;20826828,rs1800054,1,chr11,108098576,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
POLG-Q1236H,POLG,"Generally a nonpathogenic polymorphism, but may have a modifier effect that increases severity when combined in cis with other pathogenic variants.",Low,Uncertain,Pathogenic,0.058,Other,Complex/Other,Heterozygous,15917273;16595552,rs3087374,0,chr15,89859994,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
CLEC7A-Y238X,CLEC7A,This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.,Low,Uncertain,Pathogenic,0.063,Genital and urinary;Skin,Recessive,Heterozygous,19864674,rs16910526,4,chr12,10271087,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Heterozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
TFR2-R455Q,TFR2,"Hypothesized to be increase risk or severity of hemochromatosis, but only speculations based on a couple sporadic observations (no statistical significance).",Low,Uncertain,Pathogenic,0.0023,Blood,Unknown,Heterozygous,12150153;16424658,rs41303501,2,chr7,100226902,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
BCHE-G418V,BCHE,"This is the ""flu-2"" variant of BCHE and can cause prolonged post-succinylcholine apnea (an adverse side-effect of prolonged response to anesthesia) when homozygous or compound heterozygous with other deleterious BCHE variants.",High,Well-established,Pharmacogenetic,0.0036,Other,Recessive,Heterozygous,1415224,rs28933390,4,chr3,165547569,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
CYP2C9-R144C,CYP2C9,"This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.",Moderate,Well-established,Pharmacogenetic,0.097,Drug response;Metabolism,Unknown,Homozygous,8004131;15947090;17161452;17686967;19228618;19794411;19794412,rs1799853,3,chr10,96702047,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
PCSK9-R46L,PCSK9,This variant is reported to have a dominant protective effect against coronary heart disease. Carriers of this variant have about half the risk of coronary heart disease compared to non-carriers (6.3% risk in carriers vs. 11.8% risk in non-carriers).,Moderate,Likely,Protective,0.01,Heart and circulatory,Unknown,Heterozygous,16554528,rs11591147,3,chr1,55505647,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Homozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
BRCA2-T1915M,BRCA2,Serrano-Fern√°ndez et al. found this variant to be associated with a modest (OR = 1.61) but significant (P = 0.0007) reduction in breast cancer risk.  ,Low,Uncertain,Protective,0.021,Cancer,Unknown,Heterozygous,19030985,rs4987117,,chr13,32914236,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
EFHC1-R182H,EFHC1,Probably benign. OMIM appears to incorrectly interpret literature as linking this variant to juvenile myoclonic epilepsy; the authors report it as a polymorphism.,Low,Likely,Benign,0.044,Nervous system,Unknown,Heterozygous,7668263;15258581,rs3804505,,chr6,52303361,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
OCA2-R305W,OCA2,"This variant is associated with eye color, as is OCA2 Arg419Gln. Individuals with this variant are more likely to have brown/black eyes (as opposed to blue/gray or green/hazel). Other variants in this gene are associated with oculocutaneous albinism (albinism which involves skin and eyes).",Low,Likely,Benign,0.082,Hearing and vision;Skin,Unknown,Heterozygous,"12163334;
15889046",rs1800401,,chr15,28260053,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Heterozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
ELN-G581R,ELN,"Probably a benign SNP, not rare (4.8% allele frequency in GET-Evidence data).",Low,Uncertain,Benign,0.073,Other,Unknown,Heterozygous,,rs17855988,,chr7,73474825,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
NSD1-A2546T,NSD1,"Benign, reported as a polymorphism.",Low,Uncertain,Benign,0.025,Other,Unknown,Heterozygous,14571271;15720303,rs78247455,,chr5,176722005,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
GALT-N314D,GALT,"This variant has an allele frequency of ~8% and is ancestral to ""Duarte"" / ""Duarte 2"" and ""Duarte 1""/""Los Angeles"" galactosemia variants. This variant is evolutionarily ancestral, and in vitro studies fail to support an impact of this variant on enzyme activity. Carney et al. instead implicate a 4 base deletion on the 5' of the GALT gene as being causal and linked to this variant. Galactosemia is typically screened and detected in infants and causes early, severe but nonspecific symptoms (digestive problems, lethargy, failure to thrive).",Low,Uncertain,Benign,0.072,"Mouth, liver, and digestive",Unknown,Heterozygous,10408771;11261429;19224951,rs2070074,,chr9,34649442,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
MAPT-R370W,MAPT,Probably benign.,Low,Uncertain,Benign,0.16,Other,Unknown,Heterozygous,15365985,rs17651549,,chr17,44061278,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
WDR36-H212P,WDR36,Probably benign.,Low,Uncertain,Benign,0.00047,Other,Unknown,Heterozygous,18172102;19150991,,,chr5,110436345,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
KRT85-R78H,KRT85,"Presumed benign. Although this variant was implicated in causing ectodermal dysplasia in a recessive manner in two Pakistani families (one of which was large and consanguineous), GET-Evidence reports that the variant has been seen in 5 out of 114 random control chromosomes. This strongly contradicts a severe pathogenic effect.",Low,Uncertain,Benign,0.042,Skin,Recessive,Heterozygous,16525032;19865094,rs61630004,,chr12,52760957,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
PALB2-E672Q,PALB2,Probably benign.,Low,Uncertain,Benign,0.024,Other,Unknown,Heterozygous,17200668,rs45532440,,chr16,23641461,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
RAPSN-R58C,RAPSN,Reported as non-pathogenic polymorphism. ,Low,Uncertain,Benign,0.078,Other,Unknown,Heterozygous,11791205,rs34312154,,chr11,47470345,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
ABCA4-R943Q,ABCA4,"This is a polymorphism in a gene associated with Stargardt disease. Although it has a slight detectable effect in functional study, it is common in control groups and is not believed to have any significant pathogenic effect.",Low,Uncertain,Benign,0.032,Hearing and vision,Unknown,Heterozygous,9295268;11919200,rs1801581,,chr1,94512565,T,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Homozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.personalgenomes.org/genomes?display_genome_id=2e206f8157b14bc2c217d0ab5e30a857942bd56e
